ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 186 • 2017 ACR/ARHP Annual Meeting

    Paediatric Musculoskeletal (MSK) Triage in the Community – Rightpath – a Pilot Study

    Nicola Smith1, Sharmila Jandial2, Jill Firth3, Helen Light3, Katharine Kinsey3, Neil Snowden3, Judith McNaught4, Tim Rapley5, Alan Nye3 and Helen E. Foster6, 1Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom, 2Paediatric Rheumatology, Great North Children’s Hospital, Newcastle Upon Tyne, United Kingdom, 3Pennine MSK Partnership Ltd, Oldham, United Kingdom, 4Physiotherapy, South Tyneside NHS Foundation Trust, South Shields, United Kingdom, 5Institute of Health and Society, Newcastle University, Newcastle Upon Tyne, United Kingdom, 6Institute of Cellular Medicine and Paediatric Rheumatology, Newcastle University and Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom

    Background/Purpose: We are piloting a children and young people (CYP) community-based triage (called Rightpath) based on a validated adult MSK triage model developed by Pennine…
  • Abstract Number: 187 • 2017 ACR/ARHP Annual Meeting

    Improved Identification of Pseudogout in Electronic Medical Records By Adding Text String Searching to a Billing Code Algorithm

    Sara K. Tedeschi, Kazuki Yoshida and Daniel H. Solomon, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Calcium pyrophosphate deposition disease (CPPD) has a spectrum of manifestations, of which pseudogout is the most acute inflammatory phenotype. To facilitate clinical research on…
  • Abstract Number: 188 • 2017 ACR/ARHP Annual Meeting

    Lupus Low Disease Activity State Is Associated with Reduced Direct Medical Costs in Patients with Systemic Lupus Erythematosus

    Ai Li Yeo1, Rachel Koelmeyer2, Rangi Kandane-Rathnayake1, Vera Golder2, Alberta Y. Hoi2, Edward R. Hammond3, Henk Nab4, Molla Huq5, Mandana Nikpour6 and Eric F Morand7, 1Rheumatology, Monash University, Melbourne, Australia, 2Centre for Inflammatory Diseases, Monash University, Melbourne, Australia, 3AstraZeneca, Gaithersburg, MD, 4AstraZeneca, Cambridge, United Kingdom, 5Department of Medicine (Rheumatology), Melbourne University, Melbourne, Australia, 6Melbourne University, Melbourne, Australia, 7Monash University, Melbourne, Australia

    Background/Purpose: High health care utilization and direct costs have been documented in multiple studies of SLE. The recently described lupus low disease activity state (LLDAS)…
  • Abstract Number: 189 • 2017 ACR/ARHP Annual Meeting

    Challenges and Opportunities of Implementing a Patient-Reported Measure of Physical Function through an Online Electronic Health Record Patient Portal in Routine Rheumatology Practice

    Jing Li1, Jinoos Yazdany2, Laura Trupin2, Zara Izadi3, Milena Gianfrancesco1, Sarah Goglin1 and Gabriela Schmajuk4, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 3Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 4San Francisco VA Medical Center, University of California San Francisco, San Francisco, CA

    Background/Purpose: Despite significant interest in the collection of patient-reported outcomes (PROs) to make care more patient-centered, few studies have evaluated implementation efforts to collect PROs…
  • Abstract Number: 190 • 2017 ACR/ARHP Annual Meeting

    Opioid Dispensation Among Systemic Lupus Erythematosus (SLE) Patients Who Persistently Frequent the Emergency Department (ED)

    Jiha Lee1, Lisa Gale Suter2,3 and Liana Fraenkel3,4, 1Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT, 2Medicine, Rheumatol., TAC S541, Rheumatology, VA Connecticut Healthcare System, West Haven, CT, New Haven, CT, 3Rheumatology, Rheumatology, Yale University School of Medicine, New Haven, CT, New Haven, CT, 4Medicine, Section of Rheumatology, Rheumatology, VA Connecticut Healthcare System, West Haven, CT, New Haven, CT

    Background/Purpose: Patients who persistently frequent the ED are more likely to be prescribed opioids for pain, and opioid initiation in the ED has been found…
  • Abstract Number: 191 • 2017 ACR/ARHP Annual Meeting

    Is the Nature of Rheumatology Practice Changing?  Damage and Distress Contribute a Greater Proportion to Decision-Making Than Inflammation in Contemporary Care

    Theodore Pincus1, Isabel Castrejón2 and Joel A Block2, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Inflammation generally is regarded as the primary concern of rheumatologists, and measures of inflammation, such as laboratory tests and pooled indices, usually are the…
  • Abstract Number: 192 • 2017 ACR/ARHP Annual Meeting

    Patient Education Materials in Rheumatology: Only Adequate at Best

    Aleksander Lenert1 and Sujin Kim2, 1Internal Medicine, Div. of Rheumatology, University of Kentucky, Lexington, KY, 2Division of Biomedical Informatics, College of Medicine, University of Kentucky, Lexington, KY

    Background/Purpose: Low health literacy and reading ability of rheumatologic patients is associated with poor outcomes [1]. In practice, patient education is commonly delivered via patient…
  • Abstract Number: 193 • 2017 ACR/ARHP Annual Meeting

    Evaluation of a Diversionary Back Pain Service

    Lynden Roberts, Rheumatology, Monash Medical Centre, Clayton, Australia

    Background/Purpose: Surgical treatment of spinal pain is rarely indicated. Nevertheless, primary care clinician referrals to spinal surgeons for evaluation of spinal pain conditions are common.…
  • Abstract Number: 194 • 2017 ACR/ARHP Annual Meeting

    Kinesiophobia Moderates the Association between Anxiety and Disability in Chronic Low Back Pain

    Jenna Goesling1, Stephanie Moser2, Jennifer Pierce1 and Christian Bolton3, 1Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 2Anesthesiology, University of Michigan, Ann Arbor, MI, 3University of Michigan, Ann Arbor, MI

    Background/Purpose: ·         Low back pain is a debilitating and costly condition with complex biological, psychological, and social factors contributing to the development of chronic low…
  • Abstract Number: 195 • 2017 ACR/ARHP Annual Meeting

    Health Care Costs of Patients with Systemic Lupus Erythematosus (SLE) Versus Control Patients As a Function of Disease Severity: Analysis of the Betriebskrankenkassen German Sickness Fund

    Edward R. Hammond1, Heiko Friedel2, Elena Garal-Pantaler2, Marc Pignot3, Erica Velthuis4, Xia Wang1, Henk Nab5, Barnabas Desta1 and Andreas Schwarting6, 1AstraZeneca, Gaithersburg, MD, 2Team Gesundheit GmbH, Essen, Germany, 3Kantar Health GmbH, Munich, Germany, 4Evidera PPD, Utrecht Area, Netherlands, 5AstraZeneca, Cambridge, United Kingdom, 6Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany

    Background/Purpose: SLE is a chronic, debilitating, multisystem autoimmune disorder of connective tissue. In developing new treatment options, the economic burden of SLE should be quantified…
  • Abstract Number: 196 • 2017 ACR/ARHP Annual Meeting

    Patient Assistance Program Outcomes in a Community Clinic Setting

    Stephanie Cerritos1, Yanira Ruiz-Perdomo1, Natalie Tobar1, Ann Biehl2 and James D. Katz3, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Department of Pharmacy, National Institutes of Health Clinical Center, Bethesda, MD, 3National Institute of Arthritis, Musculoskeletal and Skin Disease (NIAMS), Bethesda, MD

    Background/Purpose: Uninsured rheumatic disease patients are at risk for inadequate treatment due to issues with access to care, such as medication costs that average at…
  • Abstract Number: 197 • 2017 ACR/ARHP Annual Meeting

    Process Evaluation of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Remain Employed

    Kathy Tran1, Xi yuan Li2, Xiang Chuin Seah3, Catherine Backman4, Brendan vanAs3, Pam Rogers2, Monique Gignac5, John M. Esdaile3, Carter Thorne6, Linda Li2 and Diane Lacaille7, 1Simon Fraser University, Arthritis Research Canada, Richmond, BC, Canada, 2Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, 3Arthritis Research Canada, Richmond, BC, Canada, 4Rehab Medicine, University of British Columbia, Richmond, BC, Canada, 5Instititue for Work and Health, Toronto, ON, Canada, 6University of Toronto, Newmarket, ON, Canada, 7University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada

    Background/Purpose: Inflammatory arthritis (IA) commonly affects ability to work, yet few arthritis services exist addressing employment. We report on the process evaluation of the Making…
  • Abstract Number: 198 • 2017 ACR/ARHP Annual Meeting

    The Impact of Electronic Consults (E-Consults) on Positive ANA Referrals in a Veteran Population

    Veena Patel1,2, Diana Stewart2,3 and Molly Horstman1,2,4, 1Internal Medicine, Baylor College of Medicine, Houston, TX, 2Internal Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, 3Internal Medicine and Pediatrics, Baylor College of Medicine, Houston, TX, 4Center for Innovations in Quality, Effectiveness and Safety (iQUEST), Houston, TX

    Background/Purpose: Referrals to rheumatology for positive ANA in the absence of clinical signs and symptoms is a common practice, which may lead to unnecessary resource…
  • Abstract Number: 199 • 2017 ACR/ARHP Annual Meeting

    Incremental Direct Medical Costs of Systemic Lupus Erythematosus Patients in the Years Preceding Diagnosis and the Impact of Sex: A General Population-Based Study

    Natalie McCormick1,2, Carlo Marra3 and J. Antonio Avina-Zubieta4, 1Arthritis Research Canada, Richmond, BC, Canada, 2Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada, 3School of Pharmacy, University of Otago, Dunedin, New Zealand, 4Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Little is known about the healthcare costs of systemic lupus erythematosus (SLE) patients in the years leading up to SLE diagnosis.  We estimated the…
  • Abstract Number: 200 • 2017 ACR/ARHP Annual Meeting

    Implementation and Evaluation of a Novel Nurse-Led Telemedicine Intervention for Dose Escalation of Urate-Lowering Therapy in Gout: A Clinical Practice Improvement Project

    Sen Hee Tay1,2, Bernadette Poh Lee Low3, Pamela Shi Hui Tan2, Zhi Wei Khong2, Siew Hwa Chong4, Amelia Santosa1,2, Anita Yee Nah Lim1,2 and Gim Gee Teng2,5, 1Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Singapore, 3Division of Primary Care, Department of Care Integration and Alliance, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 4Clinical Nursing Unit, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 5Division of Rheumatology, University Medicine Cluster, National University Health System, Singapore, Singapore, Singapore

    Background/Purpose:  Urate-lowering therapy (ULT) is the mainstay of gout treatment.  In our clinics, time to achieve target serum urate (SU) level during ULT titration was…
  • « Previous Page
  • 1
  • …
  • 1216
  • 1217
  • 1218
  • 1219
  • 1220
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology